These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20855214)

  • 1. 2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
    Tasdemir D; Sanabria D; Lauinger IL; Tarun A; Herman R; Perozzo R; Zloh M; Kappe SH; Brun R; Carballeira NM
    Bioorg Med Chem; 2010 Nov; 18(21):7475-85. PubMed ID: 20855214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
    Carballeira NM; Bwalya AG; Itoe MA; Andricopulo AD; Cordero-Maldonado ML; Kaiser M; Mota MM; Crawford AD; Guido RV; Tasdemir D
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4151-7. PubMed ID: 25103602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.
    Lauinger IL; Vivas L; Perozzo R; Stairiker C; Tarun A; Zloh M; Zhang X; Xu H; Tonge PJ; Franzblau SG; Pham DH; Esguerra CV; Crawford AD; Maes L; Tasdemir D
    J Nat Prod; 2013 Jun; 76(6):1064-70. PubMed ID: 23806111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids.
    Carballeira NM
    Chem Phys Lipids; 2013; 172-173():58-66. PubMed ID: 23727443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
    Carballeira NM; Cartagena M; Sanabria D; Tasdemir D; Prada CF; Reguera RM; Balaña-Fouce R
    Bioorg Med Chem Lett; 2012 Oct; 22(19):6185-9. PubMed ID: 22932312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
    Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
    J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis.
    Orhan I; Sener B; Atici T; Brun R; Perozzo R; Tasdemir D
    Phytomedicine; 2006 Jun; 13(6):388-93. PubMed ID: 16697632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marchantin A, a macrocyclic bisbibenzyl ether, isolated from the liverwort Marchantia polymorpha, inhibits protozoal growth in vitro.
    Jensen S; Omarsdottir S; Bwalya AG; Nielsen MA; Tasdemir D; Olafsdottir ES
    Phytomedicine; 2012 Oct; 19(13):1191-5. PubMed ID: 22951393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antiprotozoal and plasmodial enoyl-ACP reductase inhibition potential of turkish medicinal plants.
    Tasdemir D; Brun R; Perozzo R; Dönmez AA
    Phytother Res; 2005 Feb; 19(2):162-6. PubMed ID: 15852483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.
    Ganfon H; Bero J; Tchinda AT; Gbaguidi F; Gbenou J; Moudachirou M; Frédérich M; Quetin-Leclercq J
    J Ethnopharmacol; 2012 May; 141(1):411-7. PubMed ID: 22440261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
    Belluti F; Perozzo R; Lauciello L; Colizzi F; Kostrewa D; Bisi A; Gobbi S; Rampa A; Bolognesi ML; Recanatini M; Brun R; Scapozza L; Cavalli A
    J Med Chem; 2013 Oct; 56(19):7516-26. PubMed ID: 24063369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triterpenoids as inhibitors of erythrocytic and liver stages of Plasmodium infections.
    Ramalhete C; da Cruz FP; Lopes D; Mulhovo S; Rosário VE; Prudêncio M; Ferreira MJ
    Bioorg Med Chem; 2011 Dec; 19(24):7474-81. PubMed ID: 22071523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bis(oxyphenylene)benzimidazoles: a novel class of anti-Plasmodium falciparum agents.
    Mayence A; Vanden Eynde JJ; Kaiser M; Brun R; Yarlett N; Huang TL
    Bioorg Med Chem; 2011 Dec; 19(24):7493-500. PubMed ID: 22061825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial activity of newly synthesized chalcone derivatives in vitro.
    Yadav N; Dixit SK; Bhattacharya A; Mishra LC; Sharma M; Awasthi SK; Bhasin VK
    Chem Biol Drug Des; 2012 Aug; 80(2):340-7. PubMed ID: 22429524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
    Tasdemir D; Topaloglu B; Perozzo R; Brun R; O'Neill R; Carballeira NM; Zhang X; Tonge PJ; Linden A; Rüedi P
    Bioorg Med Chem; 2007 Nov; 15(21):6834-45. PubMed ID: 17765547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents.
    Schrader FC; Glinca S; Sattler JM; Dahse HM; Afanador GA; Prigge ST; Lanzer M; Mueller AK; Klebe G; Schlitzer M
    ChemMedChem; 2013 Mar; 8(3):442-61. PubMed ID: 23341167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II fatty acid synthesis is essential only for malaria parasite late liver stage development.
    Vaughan AM; O'Neill MT; Tarun AS; Camargo N; Phuong TM; Aly AS; Cowman AF; Kappe SH
    Cell Microbiol; 2009 Mar; 11(3):506-20. PubMed ID: 19068099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.